Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes - Wikidata - wikimedia - TriplyDB

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

http://www.wikidata.org/entity/Q35608569

about

SXR, a novel steroid and xenobiotic-sensing nuclear receptor Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia Grapefruit juice-drug interactions Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein Farnesyltransferase Renal drug transporters and their significance in drug-drug interactions Insights into CYP2B6-mediated drug-drug interactions Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element Aetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional study Genetic variability in CYP3A5 and its possible consequences.Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.The human CYP3A subfamily: practical considerations.P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs.Zonisamide in pediatric epilepsy: review of the Japanese experience.Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes.CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance.CYP3A4-mediated lopinavir bioactivation and its inhibition by ritonavir.Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction Concentrations and effects of buspirone are considerably reduced by rifampicin Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups Intravenous diltiazem and CYP3A-mediated metabolism.Pharmacokinetic variability of anticancer agents.

P2860

Q22003995-C5147BC0-12C2-4C20-AE2C-A7A5BDCD4EAF Q24558647-D6C31831-ED5A-4BC0-AF39-33299FF1E26A Q24683430-BF48399C-3BD1-4EF9-A16C-192C61F53474 Q25255438-7E71146E-33BC-4F5C-BEE3-0A02A3D796D5 Q26751444-8482E936-3990-4E94-8C82-1B2193408744 Q27646528-EEED67B0-3F1E-4367-B1C8-E13C8EB2E132 Q28071292-14EDE08E-A3E1-435C-8776-DCDEAE0AE3FE Q28078857-1014AE8C-CAE6-4167-94F3-EC5C3022AA0C Q28204828-E6857281-AFA8-4591-A879-E6A35E734EEA Q28260518-02758AA9-679D-4410-A2B3-F31A232867D4 Q28367515-6B817AA1-51E5-482F-B952-6CC02EB416B3 Q28369384-D8211678-5A33-4CB7-9690-5967AE7C11D4 Q28535816-A15EBF63-937E-4E1F-B8FB-67209C9AEE22 Q30341330-CBA18EC4-12B7-489C-873F-22D6AB0DBEEF Q33700538-989D5DD5-2949-4C87-9621-4F5343F503E8 Q33981408-11F094AD-73C2-403A-AA22-78A8EBFCC30E Q34049823-20AA5A5D-222A-4F88-9F0A-6137BBACCA0F Q34065800-E4F9CA08-1846-4A0E-8EF7-52983EC9D4AF Q34119161-F964E18B-3B52-422F-BC2F-308BEF7F6E39 Q34171741-6CDD51BC-FFCF-49DF-BBC6-C627265EBE32 Q34347566-927BD422-0732-49E8-B8C4-769071365B2F Q34357861-6DDCE38E-F22B-481B-8718-3B205319E782 Q34448305-B61ED436-67DC-45BA-9193-796277B4CC46 Q34599818-D95289B3-38C3-497A-B435-EEC3E80C8EE5 Q34604457-E84E44F2-4D04-464E-AF89-04FD951C5410 Q34627899-1460A125-8A50-4B59-B42B-5F4264C1547A Q34824471-B2FBFF5A-C408-4981-AD8B-5C0611C66AE6 Q35000765-782401D2-8832-4A28-9343-2E4C1EBEE0DD Q35041849-C75D1FD6-86F0-4ED7-AA91-CE236584FF2C Q35609347-EA3A3844-B652-4411-A5F6-05E0882942A8 Q35647173-487CB0FB-1988-4D0B-9E15-16B5EDA0F925 Q35802166-74868268-66E1-4EA1-9BB9-3B7962705543 Q35802991-DB1D21E2-876B-418F-9FB9-A876CF7A7B70 Q35825922-1446FC42-1EA0-4F25-B8A1-97AAD2F43E0B Q35826102-EDC8174B-90F8-4384-833E-606DCE72C698 Q35826448-E1AE1D21-92AB-4A3E-81AF-FE9B4016871B Q35876954-C769946A-A108-47FE-83B2-B1E03F03C3CF Q35977568-571D9EFE-AE2F-4A00-8741-3A14083E8643 Q36055276-86DF3455-7BE2-404B-AF77-FAABD4F822D8 Q36146910-C110CF3C-2857-401C-A041-56B9488F29D5

P2860

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

http://www.wikidata.org/entity/Q35608569

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@ast

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@en

type

label

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@ast

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@en

prefLabel

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@ast

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@en

P1433

Q35608569-2A593FD0-10D2-4D38-9D2E-9780076109AE

P1476

Q35608569-4D8F258B-1E0B-43BD-88B8-9759108A0742

P2093

Q35608569-4D7BE567-6792-4789-BDDE-0C9E01F35C2D

Q35608569-87EA403C-1756-44B9-A00C-0B04590FF466

Q35608569-9B176D68-C1D5-400E-A010-0FB0B453AE42

Q35608569-AC5B9724-19C8-4169-8CBF-F11735DA9CAB

Q35608569-EDDD5E7E-F9C8-4ED9-84B0-E4C036DEF98F

P2860

Q35608569-0DE9928D-361E-4966-B060-25FC8FAEA323

Q35608569-0E8D782D-AF3D-44AB-8B98-C98AE98FC841

Q35608569-11AFC1F4-55F0-40C1-B864-83A377A6ECBE

Q35608569-195AE4F9-AA13-4495-94DD-33517BCCB09B

Q35608569-19C2A358-3323-4913-8299-A4471636E265

Q35608569-23399B52-A7EC-484E-8E9B-10A6884BA7FA

Q35608569-2E984424-EB04-46C5-B9B6-B6CF6E50CF2D

Q35608569-304C975C-BB30-4BBC-9237-9189A8C7099F

Q35608569-31791D5B-AD63-4E9C-AE66-ACE5323C79D6

Q35608569-3376CD9D-96F6-4F43-BCEE-ED1C3E687DC2

P304

Q35608569-8F471517-71D6-45FC-97F1-72C012B554C9

P31

Q35608569-AFF629E8-64A9-4B7B-B861-A06B4549F8A3

P356

Q35608569-24327BE7-240D-44C1-BC5D-552535015A1F

P407

Q35608569-0824AA8E-DFC0-44AC-872F-41413A45DFE0

P433

Q35608569-886DCC85-A663-4587-AF75-68D88663DFAF

P478

Q35608569-318E5803-D17A-4598-9F3B-FA2F05BD3C70

P577

Q35608569-6FFA0430-0AD1-4C88-8C7F-D349F1C9B21C

P5875

Q35608569-2779DE77-5D48-456A-9E7E-462B408FF747

P698

Q35608569-A6CAF753-118F-4338-B723-F95B9EEF2D9B

P932

Q35608569-3289B600-F19C-4BCE-9808-3D9D722CEE3C

P356

P1433

Journal of Clinical Investigation

P1476

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

@en

P2093

C Fang

http://www.w3.org/2001/XMLSchema#string

J C Kolars

http://www.w3.org/2001/XMLSchema#string

J D Schuetz

http://www.w3.org/2001/XMLSchema#string

P B Watkins

http://www.w3.org/2001/XMLSchema#string

P Schmiedlin-Ren

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver

Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver

Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid

The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships

Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver

Cyclosporin-erythromycin interaction in renal transplant patients.

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

P304

1871-1878

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116064

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21725927

http://www.w3.org/2001/XMLSchema#string

P698

1430211

http://www.w3.org/2001/XMLSchema#string

P932

443248

http://www.w3.org/2001/XMLSchema#string